Jamieson Wellness Inc. (TSE:JWEL) Director Michael Al Pilato Sells 16,582 Shares

Jamieson Wellness Inc. (TSE:JWEL - Get Free Report) Director Michael Al Pilato sold 16,582 shares of Jamieson Wellness stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of C$28.62, for a total value of C$474,571.87.

Jamieson Wellness Trading Up 2.0 %

Shares of JWEL stock traded up C$0.57 on Monday, hitting C$29.25. 384,461 shares of the company's stock traded hands, compared to its average volume of 89,592. The stock has a market capitalization of C$1.23 billion, a price-to-earnings ratio of 30.73 and a beta of 0.63. The company's fifty day simple moving average is C$33.10 and its 200 day simple moving average is C$34.16. Jamieson Wellness Inc. has a one year low of C$23.98 and a one year high of C$38.20. The company has a debt-to-equity ratio of 75.70, a quick ratio of 1.08 and a current ratio of 2.76.

Jamieson Wellness Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Friday, March 14th will be issued a $0.21 dividend. The ex-dividend date of this dividend is Friday, March 7th. This represents a $0.84 annualized dividend and a dividend yield of 2.87%. Jamieson Wellness's dividend payout ratio is currently 88.26%.

Analyst Ratings Changes

JWEL has been the subject of several research reports. BMO Capital Markets increased their price target on shares of Jamieson Wellness from C$42.00 to C$46.00 in a research report on Thursday, December 19th. Royal Bank of Canada upped their price objective on Jamieson Wellness from C$38.00 to C$41.00 and gave the company an "outperform" rating in a research note on Tuesday, February 25th. Finally, National Bankshares boosted their target price on Jamieson Wellness from C$36.50 to C$42.00 in a research note on Monday, November 25th.

Remove Ads

About Jamieson Wellness

Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.